-
Sucampo Pharmaceuticals, Inc. was a
pharmaceutical company headquartered in Rockville,
Maryland that
focused on gastroenterology, ophthalmology, and oncology-related...
- It was
approved by the Food and Drug
Administration in 2000. In 2009,
Sucampo Pharmaceuticals acquired the
rights to the drug in the U.S. and Canada...
- is
marketed by
Takeda Pharmaceutical Company. The drug was
developed by
Sucampo Pharmaceuticals and
approved by the Food and Drug
Administration (FDA)...
- Smith,
Kline &
French (1891–2000)
Starwin (1960–2020)
Sterling (1901–1994)
Sucampo (1996–2018)
Sumitomo Chemical (pharmaceutical work from 1971–2005) Syntex...
- for up to $117 million. 2018 – In
February 2018,
Mallinckrodt acquired Sucampo Pharmaceuticals. In
December 2018 the
company announced it will spin off...
- Pharmaceuticals/Valeant
Pharmaceuticals International, Inc.
Shire Pharmaceuticals USA
Sucampo AG
Zeria Pharmaceutical Co., Ltd
Douglas Drossman,
gastroenterologist Brian...
- 2011 for $22
million to Dr.
Sachiko Kuno and Dr.
Ryuji Ueno,
founders of
Sucampo Pharmaceuticals. The
couple also own
Halcyon House,
another historic Georgetown...
